Reddy’s, Zydus Shake Hands On Next-Generation Pertuzumab In India
Reddy’s Already Offers Trastuzumab, Which Is Used With Pertuzumab
Two major Indian players have formed an alliance to bring a biosimilar to Genentech’s Perjeta to their local market, having already debuted several treatments in the HER2-positive breast cancer space.
